ArdorComm Media Group

Sunday, October 11, 2026 10:49 AM

Immunisation

Bangladesh Measles Death Toll Climbs to 585 as Outbreak Continues to Spread

Bangladesh’s measles outbreak has claimed two more lives, pushing the total death toll to 585 since March 15, according to health authorities. The latest fatalities, both involving children, were reported within a 24-hour period ending Sunday morning and have been classified as suspected measles deaths by the Directorate General of Health Services (DGHS). With these additions, the number of suspected measles-related deaths has risen to 495, while 90 deaths have been officially confirmed. The outbreak continues to place significant pressure on the country’s healthcare system, with 1,324 new suspected cases reported over the past day. This has increased the cumulative number of suspected infections to 70,936. Meanwhile, 53 new confirmed cases were recorded, taking the total confirmed infections to 9,049. Since mid-March, 56,886 people with suspected measles symptoms have been hospitalised across Bangladesh. Of these, 52,841 patients have recovered, according to DGHS data. The crisis has also sparked concerns over vaccine availability. Last week, UNICEF revealed that it had repeatedly warned Bangladesh’s previous interim administration, led by Muhammad Yunus, about vaccine shortages that could lead to a widespread outbreak. Speaking at a media briefing in Dhaka, UNICEF Bangladesh Representative Rana Flowers said the organisation had sent multiple letters and raised the issue during at least 10 meetings with health officials between 2024 and 2026. According to Flowers, UNICEF consistently cautioned authorities that delays in vaccine procurement could trigger a major public health emergency. She further noted that UNICEF Deputy Executive Director Ted Chaiban had also highlighted the issue during discussions with Bangladesh’s Foreign Ministry during his visit to the country last year. UNICEF has pledged to support the ongoing investigation launched by the current BNP-led government and provide relevant evidence regarding the vaccine shortage and the subsequent outbreak. Source: IANS

Bangladesh Measles Death Toll Climbs to 585 as Outbreak Continues to Spread Read More »

India Plans Major HPV Vaccine Push with Frontline Training and Awareness Drive

The Union Health Ministry is set to launch comprehensive capacity-building initiatives for frontline workers involved in administering the Human Papillomavirus (HPV) vaccine, as part of its ongoing efforts to prevent cervical cancer among young girls. This follows Union Finance Minister Nirmala Sitharaman’s announcement in the 2024 interim budget encouraging HPV vaccination for girls aged 9–14. Sources indicate that multiple meetings have been held by the ministry to devise a detailed strategy for the rollout. “Capacity building for frontline health workers, along with sensitization through IEC (Information, Education, and Communication) activities, is being planned for smooth implementation of the HPV vaccination program,” a senior official confirmed. The National Technical Advisory Group on Immunisation (NTAGI) had recommended the inclusion of the HPV vaccine in India’s Universal Immunisation Programme in June 2022. Currently, India has access to vaccines from MSD Pharmaceuticals and Serum Institute of India. MSD’s Gardasil 4 and Serum Institute’s Cervavac target four HPV sub-types: 6, 11, 16, and 18. Gardasil 9 — India’s first gender-neutral HPV vaccine — offers protection against nine HPV sub-types and is available for girls (9–26 years) and boys (9–15 years). The vaccines provide protection against cervical, vulvar, vaginal, and anal cancers, as well as genital warts in both males and females. Sub-types 16 and 18 are the leading causes of cervical cancer, officials noted. The World Health Organization (WHO) recommends a single-dose vaccine for optimal protection. India, home to 16% of the world’s women, accounts for nearly 25% of global cervical cancer cases and 33% of related deaths. Each year, around 80,000 Indian women are diagnosed with cervical cancer, and approximately 35,000 succumb to the disease. Source: Business Standard

India Plans Major HPV Vaccine Push with Frontline Training and Awareness Drive Read More »